Year |
Citation |
Score |
2022 |
Xiang X, Ohshiro K, Zaidi S, Yang X, Bhowmick K, Vegesna AK, Bernstein D, Crawford JM, Mishra B, Latham PS, Gough NR, Rao S, Mishra L. Impaired reciprocal regulation between SIRT6 and TGF-β signaling in fatty liver. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 36: e22335. PMID 35506565 DOI: 10.1096/fj.202101518R |
0.307 |
|
2020 |
Rao S, Ohshiro K, Zaidi S, Latham P, Jogunoori W, Nguyen B, Mishra L. Tu1661 RESISTANCE TO FATTY LIVER DISEASE, NAFLD AND NASH WITH HCC IN HOMOZYGOUS LIVER SPECIFIC CONDITIONAL LOSS OF TGF-β/SMAD3 ADAPTOR PROTEIN SPTBN1 Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)34274-8 |
0.323 |
|
2019 |
Gu S, Zaidi S, Hassan MI, Mohammad T, Malta TM, Noushmehr H, Nguyen B, Crandall KA, Srivastav J, Obias V, Lin P, Nguyen BN, Yao M, Yao R, King CH, ... ... Rao S, et al. Mutated CEACAMs Disrupt Transforming Growth Factor beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. Gastroenterology. PMID 31585122 DOI: 10.1053/J.Gastro.2019.09.023 |
0.385 |
|
2019 |
Rao S, Peri S, Hoffmann J, Cai KQ, Harris B, Rhodes M, Connolly DC, Testa JR, Wiest DL. RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. Plos One. 14: e0222392. PMID 31581233 DOI: 10.1371/Journal.Pone.0222392 |
0.38 |
|
2019 |
Ohshiro K, Zaidi S, Korkut A, Chen J, Rao S, Gu S, Jogunoori W, Mishra B, Akbani R, Mishra L. Abstract 3382: A pan-cancer analysis reveals high frequency genetic alterations in mediators of signaling by the TGF-β superfamily Cancer Research. 79: 3382-3382. DOI: 10.1158/1538-7445.Sabcs18-3382 |
0.475 |
|
2019 |
Rao S, Zaidi S, Jogunoori W, Gu S, White J, Mishra B, Deng C, Latham P, Mishra L. Abstract 4360: ALDH2 and the TGF-β/SMAD3 adaptor, Sptbn1 suppress hepatic steatosis and obesity Cancer Research. 79: 4360-4360. DOI: 10.1158/1538-7445.Am2019-4360 |
0.372 |
|
2019 |
Rao S, King CH, Mazumder R, Gu S, Amdur R, Mishra B, Mishra L. Abstract 2827: Identification of chemotherapeutic resistant microbiota profile in colorectal cancer Cancer Research. 79: 2827-2827. DOI: 10.1158/1538-7445.Am2019-2827 |
0.427 |
|
2019 |
Rao S, Shetty K, Deng C, Jogunoori W, Amdur R, Resar LS, Latham P, Mazumder R, Horvath A, Nguyen B, Zaidi S, Li S, Yu H, Wong LL, White J, et al. Mo1435 – Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer Gastroenterology. 156: S-1306. DOI: 10.1016/S0016-5085(19)40276-X |
0.353 |
|
2019 |
Gu S, Rao S, King CH, Meng Y, Jogunoori W, Amdur R, Mazumder R, Mishra L. 628 – Identification of Crosstalk Between Gut Microbiota, Ceacams, and TGF-Β Signaling in Processing Chemotherapy Response in Colon Cancer Gastroenterology. 156: S-132. DOI: 10.1016/S0016-5085(19)37119-7 |
0.382 |
|
2018 |
Rao S, Mishra L. Targeting TGF-β signaling in Liver Cancer. Hepatology (Baltimore, Md.). PMID 30549280 DOI: 10.1002/Hep.30426 |
0.42 |
|
2018 |
Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, et al. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Cell Systems. PMID 30268436 DOI: 10.1016/J.Cels.2018.08.010 |
0.435 |
|
2018 |
Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, et al. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Digestive Diseases and Sciences. PMID 29572615 DOI: 10.1007/S10620-018-5000-0 |
0.316 |
|
2018 |
Rao S, Zaidi S, Ohshiro K, Chen J, Gu S, Jogunoori W, White J, Mishra B, Li S, Akbani R, Mishra L. Abstract 5459: Regulation of IGF2 by TGF-β signaling in liver cancers and stem cell homeostasis Cancer Research. 78: 5459-5459. DOI: 10.1158/1538-7445.Am2018-5459 |
0.464 |
|
2018 |
Korkut A, Zaidi S, Kanchi R, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Schultz A, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, ... ... Rao S, et al. Abstract 3413: A pan-cancer atlas of genomic, epigenomic and transcriptomic alterations in the TGF-β pathway Cancer Research. 78: 3413-3413. DOI: 10.1158/1538-7445.Am2018-3413 |
0.441 |
|
2018 |
Zaidi S, Korkut A, Jogunoori W, Chen J, Gu S, Rao S, Ohshiro K, Akbani R, Deng C, Mishra B, Mishra L. Abstract 2226: TGF-β and CEACAMs regulated biomarkers detect early colorectal cancer Cancer Research. 78: 2226-2226. DOI: 10.1158/1538-7445.Am2018-2226 |
0.469 |
|
2018 |
Zaidi S, Chen J, Korkut A, Gu S, Rao S, Ohshiro K, Jogunoori W, Akbani R, Li S, Deng C, Mishra B, Mishra L. Mo1971 - Crosstalk Between Ceacam and Tgf-β Signaling Pathways and their Role in Colorectal Cancer Gastroenterology. 154: S-868. DOI: 10.1016/S0016-5085(18)32934-2 |
0.407 |
|
2018 |
Rao S, Zaidi S, Ohshiro K, Chen J, Akbani R, White J, Jogunoori W, Mishra B, Li S, Mishra L. 522 - Stem Cell Homeostasis in Liver Cancers is Regulated by TGF-β-IGF2 Axis Gastroenterology. 154: S-116. DOI: 10.1016/S0016-5085(18)30821-7 |
0.425 |
|
2017 |
Rao S, Zaidi S, Banerjee J, Jogunoori W, Sebastian R, Mishra B, Nguyen BN, Wu RC, White J, Deng C, Amdur R, Li S, Mishra L. Transforming growth factor-β in liver cancer stem cells and regeneration. Hepatology Communications. 1: 477-493. PMID 29404474 DOI: 10.1002/hep4.1062 |
0.38 |
|
2017 |
Gu S, Nguyen BN, Rao S, Li S, Shetty K, Rashid A, Shukla V, Deng CX, Mishra L, Mishra B. Alcohol, stem cells and cancer. Genes & Cancer. 8: 695-700. PMID 29234487 DOI: 10.18632/Genesandcancer.156 |
0.351 |
|
2017 |
Shin J, Mishra V, Glasgow E, Zaidi S, Ohshiro K, Chitti B, Kapadia AA, Rana N, Mishra L, Deng CX, Rao S, Mishra B. PRAJA is overexpressed in glioblastoma and contributes to neural precursor development. Genes & Cancer. 8: 640-649. PMID 28966725 DOI: 10.18632/Genesandcancer.151 |
0.358 |
|
2017 |
Chen J, Zaidi S, Rao S, Chen JS, Phan L, Farci P, Su X, Shetty K, White J, Zamboni F, Wu X, Rashid A, Pattabiraman N, Mazumder R, Horvath A, et al. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor beta Pathway Short title: Prognostic significance of TGF-β signature in liver cancer. Gastroenterology. PMID 28918914 DOI: 10.1053/J.Gastro.2017.09.007 |
0.377 |
|
2017 |
Rao S, Levin H, Chen J, Akbani R, White J, Jogunoori W, Gu S, Ohshiro K, Zaidi S, Mishra B, Rashid A, Li S, Mishra L. Abstract 5330: Targeting hepatocellular carcinoma through TGF-β pathway E3 ligases Cancer Research. 77: 5330-5330. DOI: 10.1158/1538-7445.Am2017-5330 |
0.419 |
|
2017 |
Rao S, Chen J, Akbani R, White J, Levin H, Jogunoori W, Gu S, Ohshiro K, Zaidi S, Mishra B, Rashid A, Li S, Mishra L. Cellular Interactions of TGF-β Pathway Members and Epigenetic Regulators of Liver and Gastrointestinal Cancers Gastroenterology. 152: S1159. DOI: 10.1016/S0016-5085(17)33884-2 |
0.431 |
|
2016 |
Rao S, Cai KQ, Stadanlick JE, Greenberg-Kushnir N, Solanki-Patel N, Lee SY, Fahl SP, Testa JR, Wiest DL. Ribosomal protein Rpl22 controls the dissemination of T cell lymphoma. Cancer Research. PMID 27197189 DOI: 10.1158/0008-5472.Can-15-2698 |
0.367 |
|
2016 |
Wang M, Ser Z, Rao S, Fahl S, Zhang Y, Peri S, Kentsis A, Wiest DL. Ribosomal Protein Rpl22 Regulates Development and Transformation Via Altering RNA Processing Blood. 128: 3878-3878. DOI: 10.1182/Blood.V128.22.3878.3878 |
0.341 |
|
2015 |
Rao S, Cai K, Stadanlick J, Lee S, Greenberg-Kushnir N, Solanki-Patel N. Novel Role for Rpl22 in Controlling Lymphoma Progression and Dissemination Blood. 126: 3669-3669. DOI: 10.1182/Blood.V126.23.3669.3669 |
0.369 |
|
2015 |
Wang M, Zhang Y, Rao S, Rhodes J, Rhodes M. Molecular Basis for Distinct, Antagonistic, Regulatory Functions of Ribosomal Protein Paralogs Rpl22 and Rpl22-Like1 (Like1) in Hematopoiesis Blood. 126: 3575-3575. DOI: 10.1182/Blood.V126.23.3575.3575 |
0.329 |
|
2015 |
Patel NS, Greenberg N, Peri S, Rao S, Rhodes M, Wiest D. Abstract B26: Role of ribosomal protein, Rpl22 in regulating leukemic transformation. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-B26 |
0.384 |
|
2015 |
Rao S, Stadanlick JE, Cai KQ, David WL. Abstract A07: Loss of Rpl22 promotes tumor progression through regulation of angiogenesis and dissemination. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-A07 |
0.393 |
|
2015 |
Rao S, Stadanlick JE, Cai KQ, Wiest DL. Abstract 5215: Loss of Rpl22 promotes tumor progression through regulation of angiogenesis Cancer Research. 75: 5215-5215. DOI: 10.1158/1538-7445.Am2015-5215 |
0.402 |
|
2015 |
Patel NS, Kushnir NG, Rao S, Peri S, Rhodes M, Nagahawatte P, Mullighan C, Wiest DL. Abstract 1269: Role of ribosomal protein, Rpl22 in regulating leukemic transformation Cancer Research. 75: 1269-1269. DOI: 10.1158/1538-7445.Am2015-1269 |
0.393 |
|
2013 |
O'Leary MN, Schreiber KH, Zhang Y, Duc AC, Rao S, Hale JS, Academia EC, Shah SR, Morton JF, Holstein CA, Martin DB, Kaeberlein M, Ladiges WC, Fink PJ, Mackay VL, et al. The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1. Plos Genetics. 9: e1003708. PMID 23990801 DOI: 10.1371/Journal.Pgen.1003708 |
0.316 |
|
2013 |
Zhang Y, Duc AC, Rao S, Sun XL, Bilbee AN, Rhodes M, Li Q, Kappes DJ, Rhodes J, Wiest DL. Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs. Developmental Cell. 24: 411-25. PMID 23449473 DOI: 10.1016/J.Devcel.2013.01.018 |
0.355 |
|
2013 |
Wu F, Peacock SO, Rao S, Lemmon SK, Burnstein KL. Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth. The Journal of Biological Chemistry. 288: 5463-74. PMID 23281476 DOI: 10.1074/Jbc.M112.390963 |
0.634 |
|
2012 |
Rao S, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu Z, Jeffers JR, Rhodes M, Anderson S, Oravecz T, Hunger SP, Timakhov RA, Zhang R, Balachandran S, Zambetti GP, et al. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood. 120: 3764-73. PMID 22976955 DOI: 10.1182/Blood-2012-03-415349 |
0.363 |
|
2012 |
Rao S, Lyons LS, Fahrenholtz CD, Wu F, Farooq A, Balkan W, Burnstein KL. A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer. Oncogene. 31: 716-27. PMID 21765461 DOI: 10.1038/Onc.2011.273 |
0.624 |
|
2008 |
Gu H, Wang X, Rao S, Wang J, Zhao J, Ren FL, Mu R, Yang Y, Qi Q, Liu W, Lu N, Ling H, You Q, Guo Q. Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells. Molecular Cancer Therapeutics. 7: 3298-305. PMID 18852133 DOI: 10.1158/1535-7163.Mct-08-0212 |
0.335 |
|
2008 |
Lyons LS, Rao S, Balkan W, Faysal J, Maiorino CA, Burnstein KL. Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer. Molecular Endocrinology (Baltimore, Md.). 22: 597-608. PMID 18079321 DOI: 10.1210/Me.2007-0158 |
0.623 |
|
Show low-probability matches. |